SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-20-010298
Filing Date
2020-06-01
Accepted
2020-06-01 17:27:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 sc13d.htm SC 13D 119843
2 exhibita.htm EX-99.A CHARTER 7026
3 exhibitb.htm EX-99.A CHARTER 117505
  Complete submission text file 0001493152-20-010298.txt   246152
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Subject) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51647 | Film No.: 20934821
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1370 HAMILTON STREET SOMERSET NJ 08873
Business Address 1370 HAMILTON STREET SOMERSET NJ 08873 732-543-2440
Nostrum Pharmaceuticals, LLC (Filed by) CIK: 0001811885 (see all company filings)

IRS No.: 260476064
Type: SC 13D